Gastric bypass might not have long-term benefits in diabetes

11/28/2012 | New York Times (tiered subscription model), The

Thirty-five percent of type 2 diabetes patients who initially experienced disease remission following gastric bypass surgery redeveloped diabetes within five years, while many patients never attained remission after the procedure, a study in Obesity Surgery found. Surgery appeared to be most effective for type 2 diabetes patients without advanced disease, researchers said.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health